IRIS
PIGNATA, SALVATORE ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.847
NA - Nord America 1.752
AS - Asia 904
SA - Sud America 338
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 4.885
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.705
RU - Federazione Russa 555
SG - Singapore 397
IT - Italia 325
IE - Irlanda 312
BR - Brasile 296
SE - Svezia 252
CN - Cina 240
DE - Germania 132
HK - Hong Kong 102
FR - Francia 62
PL - Polonia 55
FI - Finlandia 46
IN - India 44
VN - Vietnam 40
GB - Regno Unito 34
CA - Canada 25
AR - Argentina 16
JP - Giappone 14
NL - Olanda 13
ZA - Sudafrica 13
AT - Austria 12
CI - Costa d'Avorio 12
BE - Belgio 11
IQ - Iraq 11
BD - Bangladesh 10
ES - Italia 10
MX - Messico 8
TR - Turchia 7
LT - Lituania 6
PA - Panama 6
CL - Cile 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
ID - Indonesia 5
UZ - Uzbekistan 5
VE - Venezuela 5
AU - Australia 4
MA - Marocco 4
PK - Pakistan 4
A1 - Anonimo 3
AZ - Azerbaigian 3
PE - Perù 3
PY - Paraguay 3
SA - Arabia Saudita 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CO - Colombia 2
CR - Costa Rica 2
GE - Georgia 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BS - Bahamas 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
SN - Senegal 1
UY - Uruguay 1
Totale 4.885
Salva come PNG Salva come JPEG
Città #
Dublin 310
Chandler 295
Ashburn 278
Moscow 274
Singapore 221
Dallas 218
Nyköping 176
Hong Kong 102
Beijing 93
Munich 67
Princeton 53
Warsaw 52
Messina 48
The Dalles 48
Medford 41
Los Angeles 39
Dearborn 35
Des Moines 34
Bremen 33
Jacksonville 29
New York 29
Ann Arbor 27
São Paulo 24
Hyderabad 22
Rome 22
Helsinki 21
Buffalo 18
Turku 16
Milan 15
Frankfurt am Main 13
Ho Chi Minh City 13
Redondo Beach 13
Tianjin 13
Abidjan 12
Boardman 12
Cambridge 12
Jinan 12
Montreal 12
Brussels 11
Kameido 10
London 10
Hanoi 9
Dong Ket 8
Düsseldorf 8
Falls Church 8
Nanjing 8
Palermo 8
Shenyang 8
Belo Horizonte 7
Denver 7
Johannesburg 7
Nuremberg 7
Orem 7
Pune 7
Rio de Janeiro 7
Santa Clara 7
Stockholm 7
Vienna 7
Wilmington 7
Atlanta 6
Boston 6
Brasília 6
Chennai 6
Curitiba 6
Fuzhou 6
Hebei 6
Nanchang 6
Redwood City 6
Seattle 6
Vittoria 6
West Jordan 6
Brooklyn 5
Council Bluffs 5
Hangzhou 5
Phoenix 5
Porto Alegre 5
Santa Domenica 5
Taizhou 5
Toronto 5
Bexley 4
Blumenau 4
Catania 4
Changsha 4
Houston 4
Jakarta 4
Leeds 4
Ningbo 4
Panama City 4
Pescara 4
Salvador 4
San Francisco 4
San Mateo 4
Sorocaba 4
Tashkent 4
Tokyo 4
Waverly Hall 4
Zhengzhou 4
Baghdad 3
Baku 3
Basra 3
Totale 3.110
Salva come PNG Salva come JPEG
Nome #
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 285
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 229
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience 157
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 153
223RA-dichloride use in patients affected by bone metastases from castration-resistant prostate cancer: single centre experience 149
Prognostic Validity of Dual Tracer PET/CT in the PRRT Enrollment of GEP-NET Patients 147
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 146
Association of parathyroid carcinoma and thyroid disorders: A clinical review 144
99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 143
Complete Response in a Pancreatic Nen with Liver Metastasis after PRRT in association with Lanreotide Autogel/depot: Design of the Prelude Study 142
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy 139
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 134
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 130
Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot 124
Usefulness of PET-CT scan in recurrent thyroid cancer 123
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 122
PRRT retreatments: renal function evaluation 121
Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study 121
Renal Function Evaluation in PRRT Retreatments 119
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 118
Prognostic Validity of Dual Tracer PET/CT In The PRRT Enrollment of GEP-NET Patients 116
un caso di carcinoma delle paratiroidi associato ad adenoma autonomo omolaterale della tiroide 110
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 110
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 109
Is dual tracer PET/CT a prognostic biomarker in the PRRT enrollment of GEP-NET patients? 106
Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients 106
From clinical trials to the front line: Vinflunine for treatment of urothelial cell carcinoma at the National Cancer Institute of Naples 104
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 101
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario 100
Can peptide receptor radionuclide therapy (PRRT) be useful in radioiodine-refractory differentiated thyroid cancer? 98
Pazopanib in metastatic renal cancer: A "real-world" experience at National Cancer Institute "Fondazione G. Pascale" 95
Corrigendum: Pazopanib in metastatic renal cancer: A "real-world" experience at national cancer institute "Fondazione G. Pascale" [Front. Pharmacol., 7, 287, (2016)] doi: 10.3389/fphar.2016.00287 94
Very early PSA response to abiraterone in mCRPC patients: A novel prognostic factor predicting overall survival 89
Theranosticsin nuclear medicine and oncology 87
The sensitivity and positive predictive value (PPV) of I-131-post-therapy whole body scan is higher than serum Tg values in detecting metastases in early stage of differentiated thyroid cancer patients 86
Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: The prospective observational scoop trial results 85
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223 84
Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients 75
Post-operative radioiodine therapy (RaIT) as adjuvant therapy in low–intermediate risk differentiated thyroid cancer 68
Peptide receptor radionuclide therapy plus somatostatin analogues for a neuroendocrine tumour combined and maintenance treatment 49
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose 48
Sequencing radium 223 (RA223) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the daily practice: Preliminary results from a retrospective study in Italian centers 45
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra 33
null 24
null 23
null 16
Totale 5.007
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.374
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021124 0 0 0 0 0 6 10 33 32 12 19 12
2021/2022355 6 35 6 7 21 10 8 28 5 39 48 142
2022/2023996 86 128 48 84 71 90 17 58 369 10 22 13
2023/2024243 20 26 13 28 24 42 16 12 0 27 5 30
2024/20251.106 12 30 18 51 78 38 34 209 261 80 141 154
2025/20261.664 222 177 244 140 250 631 0 0 0 0 0 0
Totale 5.007